We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Recommendations for New Global Cancer Scanning Biomarkers

By MedImaging International staff writers
Posted on 26 Oct 2016
Print article
Image: An MRI scanner used for cancer diagnosis (Photo courtesy of Imperial College London).
Image: An MRI scanner used for cancer diagnosis (Photo courtesy of Imperial College London).
A team of 78 experts from Europe and North America has identified 14 key recommendations for a new global standard for cancer scanning biomarkers.

The recommendations are intended to help researchers submit grants, increase reproducibility between laboratories, help researchers compare scans with other tests, and for cost-effectness. The recommendations were published in the October 11, 2016, issue of Nature Reviews Clinical Oncology.

The team included researchers from the CRUK-EPSRC Cancer Imaging Centres (Cambridge and Manchester, UK), and the European Organization for Research and Treatment of Cancer (EORTC; Brussels, Belgium).

Clinicians today use Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Positron Emission Tomography (PET) scans to provide 3D representations of tumors to help with the diagnosis, staging, and treatment planning for cancer. New scanning techniques often provide new and improved biomarkers, but their implementation for the treatment of cancer patients is often slow, because of a lack of standardization. The new techniques could be tested more effectively in clinical trials if scanners from different manufacturers were calibrated similarly in different hospitals.

Clinical Leader for the Medical and TRI Department at EORTC, Yan Liu, said, "Academic research can play a critical role in ensuring fundamental research and technological innovation reach patients. This collaboration is a great example of how organizations can bring expertise together to identify and resolve issues in getting the imaging biomarkers introduced into clinical practice to make a bigger impact on people's lives."

Related Links:
CRUK-EPSRC Cancer Imaging Centres
European Organization for Research and Treatment of Cancer
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom
Color Doppler Ultrasound System
DRE Crystal 4PX
New
Ceiling-Mounted Digital Radiography System
Radiography 5000 C

Print article

Channels

Ultrasound

view channel
Image: The AI-powered Point Of Care Assisted Diagnosis (POCAD) solution is transforming the medical ultrasound industry (Photo courtesy of AISAP)

First AI-Powered POC Ultrasound Diagnostic Solution Helps Prioritize Cases Based On Severity

Ultrasound scans are essential for identifying and diagnosing various medical conditions, but often, patients must wait weeks or months for results due to a shortage of qualified medical professionals... Read more

Nuclear Medicine

view channel
Image: The multi-spectral optoacoustic tomography (MSOT) machine generates images of biological tissues (Photo courtesy of University of Missouri)

New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure

Imaging inflammation using traditional radiological techniques presents significant challenges, including radiation exposure, poor image quality, high costs, and invasive procedures. Now, new contrast... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more